SAL0167
/ Shenzhen Salubris
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 09, 2026
A study evaluating the effects of different administration routes on the pharmacokinetics of SAL0167 tablets in healthy adult Chinese participants.
(chinadrugtrials.org.cn)
- P1 | N=12 | Not yet recruiting | Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
New P1 trial • Dyslipidemia
July 24, 2026
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0167 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=120 | Not yet recruiting | Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
New P1 trial • Dyslipidemia
1 to 2
Of
2
Go to page
1